HMG-CoA reductase is regulated by salinity at the level of transcription in Haloferax volcanii

被引:29
|
作者
Bidle, Kelly A.
Hanson, Thomas E.
Howell, Koko
Nannen, Jennifer
机构
[1] Rider Univ, Dept Biol, Lawrenceville, NJ 08648 USA
[2] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA
[3] Univ Delaware, Grad Coll Marine Studies, Newark, DE 19711 USA
基金
美国国家科学基金会;
关键词
haloarchaea; HMG-CoA reductase; salt regulation; lipids; carotenoids;
D O I
10.1007/s00792-006-0008-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The moderately halophilic archaeon Haloferax volcanii was surveyed for protein profile changes correlated with growth at high and low salinity. A single polypeptide with an approximate mass of 46 kDa was conspicuously more abundant during growth at high salinity. This protein was identified as HMG-CoA reductase (HMGR), encoded by the hmgR gene. HMGR is a key enzyme in the mevalonate pathway of isoprenoid biosynthesis, the sole route in haloarchaea for lipid and carotenoid production. Enzymatic assays confirmed that HMGR activity is more abundant in cells grown at high salinity. Low salt cultures of H. volcanii contained lower amounts of hmg R transcript compared to cells grown in high salt suggesting that the observed regulation occurs at the level of transcription. Paradoxically, both lipid and carotenold content decreased in H. volcanii grown at high salinity despite the increased levels of HMGR specific activity. To our knowledge, this is the first report demonstrating that the expression of HMGR is regulated in response to non-optimal salinity in a halophilic archaeon.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [21] HMG-CoA Reductase Inhibitors for Prevention and Treatment of Severe Sepsis
    Joel D. Mermis
    Steven Q. Simpson
    Current Infectious Disease Reports, 2012, 14 : 484 - 492
  • [22] The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein
    Ness, GC
    Chambers, GM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (01) : 41 - 44
  • [23] HMG-CoA Reductase Inhibitors as Drug Leads against Naegleria fowleri
    Hahn, Hye Jee
    Abagyan, Ruben
    Podust, Larissa M.
    Roy, Shantanu
    Ali, Ibne Karim M.
    Debnath, Anjan
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (19): : 3089 - 3096
  • [24] Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase
    Subrata Chakraborty
    Shih-Hung Lin
    David Shiuan
    Dar-Fu Tai
    Amino Acids, 2015, 47 : 1495 - 1505
  • [25] Peptide inhibitors of human HMG-CoA reductase as potential hypocholesterolemia agents
    Lin, Shih-Hung
    Chang, Ding-Kwo
    Chou, Mei-Ju
    Huang, Kao-Jean
    Shiuan, David
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (01) : 104 - 109
  • [26] (TTA)n repeat polymorphism in the HMG-CoA reductase gene and cholesterolaemia
    Hubacek, JA
    Pistulková, H
    Valenta, Z
    Poledne, R
    VASA-JOURNAL OF VASCULAR DISEASES, 1999, 28 (03): : 169 - 171
  • [27] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    L. R. Whitfield
    R. H. Stern
    A. J. Sedman
    R. Abel
    D. M. Gibson
    European Journal of Drug Metabolism and Pharmacokinetics, 2000, 25 : 97 - 101
  • [28] Lepidopteran HMG-CoA reductase is a potential selective target for pest control
    Li, Yuan-mei
    Kai, Zhen-peng
    Huang, Juan
    Tobe, Stephen S.
    PEERJ, 2017, 5
  • [29] Syntheses of some α-cyclic tripeptides as potential inhibitors for HMG-CoA Reductase
    Chakraborty, Subrata
    Lin, Shih-Hung
    Shiuan, David
    Tai, Dar-Fu
    AMINO ACIDS, 2015, 47 (08) : 1495 - 1505
  • [30] CLINICAL-PHARMACOLOGY OF PRAVASTATIN, A SELECTIVE INHIBITOR OF HMG-COA REDUCTASE
    PAN, HY
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 : S15 - S18